Cristina Quintavalle

6PUBLICATIONS
52CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markersMolecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 15, 2026
Sex-related susceptibility to pulmonary fibrosis development in mice.

Danilo D'Avino, Ida Cerqua, Lucianna Maruccio

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Apr 23, 2024
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.

Carolina Giordano, Laura Marrone, Simona Romano

|Oct 27, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.

Cristina Quintavalle, Sravanth Kumar Hindupur, Luca Quagliata

|Aug 12, 2017
Persistent serum creatinine increase following contrast-induced acute kidney injury.

Carlo Briguori, Cristina Quintavalle, Francesca De Micco

|May 04, 2017
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.

Cristina Quintavalle, Katharina Burmeister, Salvatore Piscuoglio

Pageof 1